Obesity induces metabolic disturbances in adipose tissue, influencing the release of hormones, adipokines, inflammatory cytokines, growth factors, enzymes, and free fatty acids [12]
105 Similarly, loss of KMT2C promotes a transition to DNPC, further contributing to AR therapy resistance
This process may contribute to a reduction in lipid accumulation
By targeting all three pathways at once, retatrutide does more than simply reduce hunger
Therapeutic doses of vitamin C may act against cancer development and progression through several other mechanisms, such as stimulating immune system activation or enhancing the chemosensitivity of cancer cells, but evidence beyond preclinical models is still lacking (124, 125)